miR-421 is a diagnostic and prognostic marker in patients with osteosarcoma
- PMID: 26758431
- DOI: 10.1007/s13277-015-4578-5
miR-421 is a diagnostic and prognostic marker in patients with osteosarcoma
Abstract
MicroRNAs (miRNAs) are a new class of prognostic and diagnostic biomarkers for many cancers. Recent studies have shown that miRNAs are highly stable in plasma/serum. The aim of this study was to investigate the role of miR-421 in osteosarcoma. We found that the serum expression levels of miR-421 were significantly higher in osteosarcoma patients than those in healthy volunteers. Moreover, miR-421 expression was significantly higher in osteosarcoma tissues compared with that in the adjacent normal tissues. Meanwhile, the expression of miR-421 was upregulated in 90 % (36/40) osteosarcoma tissues compared to non-tumor tissues. More importantly, the expression levels of miR-421 in osteosarcoma tissues were correlated with those in patients' serum. In addition, patients with high miR-421 expression had shorter overall survival (OS) than those with low expressions. We also found that overexpression of miR-421 promoted osteosarcoma cell line MG-63 proliferation, migration, and invasion. In conclusion, miR-421 expression levels were upregulated in osteosarcoma tissue and serum and it may be a useful marker for diagnosis of osteosarcoma.
Keywords: Invasion; MicroRNAs; Osteosarcoma; Serum miRNA; miR-421.
Similar articles
-
Serum microRNA-221 functions as a potential diagnostic and prognostic marker for patients with osteosarcoma.Biomed Pharmacother. 2015 Oct;75:153-8. doi: 10.1016/j.biopha.2015.07.018. Epub 2015 Sep 28. Biomed Pharmacother. 2015. PMID: 26422796
-
A four serum-miRNA panel serves as a potential diagnostic biomarker of osteosarcoma.Int J Clin Oncol. 2019 Aug;24(8):976-982. doi: 10.1007/s10147-019-01433-x. Epub 2019 May 20. Int J Clin Oncol. 2019. PMID: 31111286
-
MicroRNA-185 inhibits proliferation, migration and invasion in human osteosarcoma MG63 cells by targeting vesicle-associated membrane protein 2.Gene. 2019 May 15;696:80-87. doi: 10.1016/j.gene.2019.01.034. Epub 2019 Feb 2. Gene. 2019. PMID: 30721745
-
Role of exosomal miR‑21 in the tumor microenvironment and osteosarcoma tumorigenesis and progression (Review).Int J Oncol. 2020 May;56(5):1055-1063. doi: 10.3892/ijo.2020.4992. Epub 2020 Feb 19. Int J Oncol. 2020. PMID: 32319566 Review.
-
Insights into the roles of miRNAs; miR-193 as one of small molecular silencer in osteosarcoma therapy.Biomed Pharmacother. 2019 Mar;111:873-881. doi: 10.1016/j.biopha.2018.12.106. Epub 2019 Jan 8. Biomed Pharmacother. 2019. PMID: 30841466 Review.
Cited by
-
Biopsy Techniques for Musculoskeletal Tumors: Basic Principles and Specialized Techniques.Curr Oncol. 2024 Feb 5;31(2):900-917. doi: 10.3390/curroncol31020067. Curr Oncol. 2024. PMID: 38392061 Free PMC article. Review.
-
Multi-Anticancer Activities of Phytoestrogens in Human Osteosarcoma.Int J Mol Sci. 2023 Aug 28;24(17):13344. doi: 10.3390/ijms241713344. Int J Mol Sci. 2023. PMID: 37686148 Free PMC article. Review.
-
Serum-Derived microRNAs as Prognostic Biomarkers in Osteosarcoma: A Meta-Analysis.Front Genet. 2020 Aug 11;11:789. doi: 10.3389/fgene.2020.00789. eCollection 2020. Front Genet. 2020. PMID: 32849795 Free PMC article.
-
Circular RNA circCCDC66 Contributes to Malignant Phenotype of Osteosarcoma by Sponging miR-338-3p to Upregulate the Expression of PTP1B.Biomed Res Int. 2020 Aug 10;2020:4637109. doi: 10.1155/2020/4637109. eCollection 2020. Biomed Res Int. 2020. Retraction in: Biomed Res Int. 2024 Mar 20;2024:9753268. doi: 10.1155/2024/9753268. PMID: 32851074 Free PMC article. Retracted.
-
MicroRNAs with prognostic significance in osteosarcoma: a systemic review and meta-analysis.Oncotarget. 2017 Jul 5;8(46):81062-81074. doi: 10.18632/oncotarget.19009. eCollection 2017 Oct 6. Oncotarget. 2017. PMID: 29113367 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical